Evidence map›Paper›PMID 34836165›Full record

ArticleNutrients2021

Antiviral Activity and Underlying Action Mechanism of Euglena Extract against Influenza Virus.

Ayaka Nakashima, Yuka Horio, Kengo Suzuki, Yuji Isegawa

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Food science & nutrition · 2025
    Article
  3. Article
  4. Unveiling Immunomodulatory Effects ofJournal of microbiology and biotechnology · 2024
    Article
  5. Activation of Immune and Antiviral Effects byFoods (Basel, Switzerland) · 2023
    Review
  6. Anti-Influenza Virus Activity ofFoods (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Integrative cancer therapies
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ayaka NakashimaEuglena Co., Ltd., Tokyo 108-0014, Japan.
Yuka HorioDepartment of Food Sciences and Nutrition, School of Human Environmental Sciences, Mukogawa Women's University, Nishinomiya 663-8558, Japan.
Kengo SuzukiEuglena Co., Ltd., Tokyo 108-0014, Japan.
Yuji IsegawaDepartment of Food Sciences and Nutrition, School of Human Environmental Sciences, Mukogawa Women's University, Nishinomiya 663-8558, Japan.ORCID 0000-0001-9701-8431
Mukogawa Women's University · JP

Funding

Japan Science and Technology Agency Grant Number JPMJOP1832, Japan.
6 · The paper itself

Abstract

It is difficult to match annual vaccines against the exact influenza strain that is spreading in any given flu season. Owing to the emergence of drug-resistant viral strains, new approaches for treating influenza are needed.

Indexed as

Antiviral AgentsEuglenaAnimalsComplex MixturesDogsInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza B virusMadin Darby Canine Kidney CellsVirus ReplicationZincZinc AcetateAntiviral AgentsComplex MixturesZincZinc Acetateantiviral effectEuglena extractEuglena gracilisinfluenza viruszinc

Identifiers

PMID34836165
PMCPMC8624635
OpenAlexW3211236120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.